Cargando…

One year of COVID-19 pandemic: Health care workers’ infection rates and economical burden in medical facilities for oral and maxillofacial surgery

The aim of this study was to create an overview on the COVID-associated burdens faced by the oral and maxillofacial surgery (OMS) workforce during 1 year of the pandemic. OMS hospitals and private practices nationwide were surveyed regarding health care worker (HCW) screening, infection status, pre-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachmann, Ella, Zellmer, Stephan, Kahn, Maria, Muzalyova, Anna, Ebigbo, Alanna, Al-Nawas, Bilal, Ziebart, Thomas, Meisgeier, Axel, Traidl-Hoffmann, Claudia, Eckstein, Fabian, Messmann, Helmut, Schlittenbauer, Tilo, Römmele, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637287/
https://www.ncbi.nlm.nih.gov/pubmed/36402637
http://dx.doi.org/10.1016/j.jcms.2022.10.001
Descripción
Sumario:The aim of this study was to create an overview on the COVID-associated burdens faced by the oral and maxillofacial surgery (OMS) workforce during 1 year of the pandemic. OMS hospitals and private practices nationwide were surveyed regarding health care worker (HCW) screening, infection status, pre-interventional testing, personal protective equipment (PPE), and economic impact. Participants were recruited via the German Society for Oral and Maxillofacial Surgery. A total of 11 hospitals (416 employees) and 55 private practices (744 employees) participated. The HCW infection rate was significantly higher in private practices than in clinics (4.7% vs. 1.4%, p<0.01), although most infections in HCW occurred in private environment (hospitals 88.2%, private practice 66.7%). Pre-interventional testing was performed significantly less for outpatients in private practices than in hospitals (90.7% vs. 36.4%, p<0.01). Polymerase chain reaction (PCR) was used significantly more for inpatients in hospitals than in private practices (100.0% vs. 27.3%, p<0.01). FFP2/3 use rose significantly in hospitals (0% in second quarter vs. 46% in fourth quarter, p<0.05) and private practices (15% in second quarter vs. 38% in fourth quarter, p<0.01). The decrease in procedures (≤50%) was significantly higher in hospitals than in private practices (90.9% vs. 40.0%, p<0.01). Despite higher infection rates in private practices, declining procedures and revenue affected hospitals more. Future COVID-related measures must adjust the infrastructure especially for hospitals to prevent further straining of staff and finances.